Ilan Merdler retweeted
In this review will seek to highlight prior studies and future directions in the treatment of acute coronary syndrome in patients with rheumatologic disease.
Great work by @IlanMerdler @andrew_p_hill @GTCardFellows @MedStarHealth
Check out our recent review on ACS and the burgeoning field of Cardio-Rheumatology
pubmed.ncbi.nlm.nih.gov/4009…
Thanks to Shaikh Iqbal @IlanMerdler @BCase07
Ilan Merdler retweeted
Check out our recent review on ACS and the burgeoning field of Cardio-Rheumatology
pubmed.ncbi.nlm.nih.gov/4009…
Thanks to Shaikh Iqbal @IlanMerdler @BCase07
Ilan Merdler retweeted
Action packed day at #CRT2025 discussing all our important work #CMD @CRT_meeting @IlanMerdler @KalChitturi @ron_waksman @HashimHayder @GiorgioMedranda @IAmDoctorAbhi
Ilan Merdler retweeted
Published #JACCINT our global survey understanding the perspective of IC in regards to CFT. Overcoming misconceived barriers and performing uniform testing is still needed. @IlanMerdler @KalChitturi @ron_waksman @HashimHayder @JACCJournals @CRT_meeting
doi.org/10.1016/j.jcin.2024.…
Ilan Merdler retweeted
Does epicardial fat play a role in coronary microvascular dysfunction (CMD)? 🤔Our new study suggests a link between increased epicardial fat index and CMD. More studies needed, but our research could be a key to better CMD diagnosis & treatment!
doi.org/10.1161/JAHA.124.038…
#cardiology #CMD #CardioTwitter #MustRead @ACCinTouch @GTCardFellows
@BCaseMD1 @KalChitturi @IAmDoctorAbhi @lior_lupu @haberdan @HashimHayder @DorBen @MedStarWHC @JAHA_AHA
Ilan Merdler retweeted
Our article on #CMD in Cancer Patients with #ANOCA, led by ⭐️@IlanMerdler, is now out in @RevEspCardiol, official journal of @secardiologia 🎊
@BCase07 @HashimHayder @ron_waksman @hect2701 @GTCardFellows @ACCDCchapter @CRT_meeting @SCAI #CardioTwitter
🔗 rb.gy/zh4lzz
Ilan Merdler retweeted
@ELS_Cardiology @AlokeFinn @NHLBI_Translate @GiorgioMedranda @IlanMerdler @BhogalSukhdeep @MohitpahujaMD @AnwarChahal @HenrytTimothy @CRT_meeting
Ilan Merdler retweeted
PROTECT IV is enrolling high-risk PCI with or without Impella with a sample size estimate of 1252 patients. Our center's 2-year outcome is 30.8 %, we estimate that PROTECT IV requires 1966 patients, demonstrating that PROTECT IV is probably underpowered.
pubmed.ncbi.nlm.nih.gov/3901…
Ilan Merdler retweeted
Just accepted in @CRMjournal+@ELS_Cardiology!
Impact of #LBBBor permanent #PPM after #TAVR #TAVI on mid-term #LVEF by @IlanMerdler @BCase07 @KalChitturi @DorBen @ronwaksman et al.
clinicalkey.com/#!/content/p…
Ilan Merdler retweeted
The 2nd episode of “The Fellows’ Call” is now out, where we discuss the need for an abbreviated duration and more efficient pathways of training in medicine subspecialities ✨
Check out the link 👉🏻 rb.gy/u5the6 & let us know what you think!
#CardioTwitter #ACCFIT
Ilan Merdler retweeted
Just published in @CircIntv: Our State-of-the-Art Review on Bioprosthetic #Aortic #Valve Thrombosis, in which we discuss the incidence, mechanisms, diagnosis, and management of subclinical and clinical leaflet #thrombosis.
bit.ly/4bSGDlg
#cardiotwitter #YesCCT #TAVR
Ilan Merdler retweeted
Just published in @CRMjournal Interesting Cases! We describe primary closure of the aorto-caval tract after #transcaval #TAVR with a covered stent in a small sized abdominal aorta.
bit.ly/3ypOyYo
@IlanMerdler @lior_lupu @BCase07 @ron_waksman @DorBen #TobyRogers
Ilan Merdler retweeted
From Chest Pain to #Coronary Function Testing: Clinical and Economic Impact of Coronary Microvascular Dysfunction #CMD with @BCase07 and @IlanMerdler
crtonline.org/video-detail/f…
Ilan Merdler retweeted
Just accepted in @CRMjournal+@ELS_Cardiology!
Unveiling the value of left ventriculography in #STEMI by @IlanMerdler @BCase07 @DorBen @ron_waksman et al.
clinicalkey.com/#!/content/p…
Ilan Merdler retweeted
Our State of the Art Review in @EuroInterventio discussing inflammation in atherosclerosis, biomarkers, therapeutic options (strengths/limitations) future advancements, and notable clinical studies. Also, an algorithm for residual inflammatory risk (RIR). eurointervention.pcronline.c…
Ilan Merdler retweeted
Drs. @BCaseMD1, @ron_waksman, et al. sought to identify racial and ethnic disparities in the enrollment of minority patients into CV clinical trials at a large tertiary urban research health care center: bit.ly/3MCavb4
#JACCINT #HealthDisparities #ClinicalTrials

























